【レポートの概要（一部）】
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Disease overview: Diabetes
• Diagnosis of diabetes
• Complications associated with high blood glucose levels
PART 06: Pipeline portfolio
• Pipeline for new drug application (NDA) filings
• Pipeline for Phase III molecules
• Pipeline for Phase II molecules
• Pipeline for Phase I molecules
• Pipeline for pre-clinical stage molecules
• Pipeline for discovery stage molecules
PART 07: Market landscape
• Market overview
• Five forces analysis
PART 08: Overview of marketed products
• Synopsis of key diabetic drugs
• Marketed product profiles
PART 09: Market segmentation by type of disease
• Global type 1 diabetes market
• Global type 2 diabetes market
• Global gestational diabetes market
PART 10: Market segmentation by drug class
• Insulin therapies
• Non-insulin therapies
PART 11: Geographical segmentation
• Diabetic therapeutic market in Americas
• Diabetic therapeutic market in US
• Diabetic therapeutic market in EMEA
• Diabetic therapeutic market in Europe
• Diabetic therapeutic market in Germany
• Diabetic therapeutic market in UK
• Diabetic therapeutic market in France
• Diabetic therapeutic market in Italy
• Diabetic therapeutic market in Spain
• Diabetic therapeutic market in APAC
• Diabetic therapeutic market in China
• Diabetic therapeutic market in India
PART 12: Market drivers4
• Change in patient preference
• Focus on self-management of diabetes
• The strong potential of biologics
• Unmet medical needs and scope for DMDs
PART 13: Impact of drivers
PART 14: Market challenges
• Complex storage conditions and distribution policies for insulin
• Unpredictable outcomes on human due to lack of predictable animal models
• Gap in nation-level diabetes management plans
• Rising concerns in the scientific community
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Focus on oral insulin therapies
• Growing technological integration fueling the market growth
• Focus on regenerative medicines
• Strong and diversified pipeline portfolio
PART 17: Vendor landscape8
• Competitive scenario
• Market analysis 2016
• Upcoming vendors for oral insulin therapies
• Oramed Pharmaceuticals
• Generex Biotechnology
• Other prominent vendors
PART 18: Key vendor analysis
• Novo Nordisk
• Sanofi
• Merck
• Eli Lilly
• AstraZeneca
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Types of diabetes
Exhibit 03: Diagnosis of diabetes
Exhibit 04: Market share of pipeline molecules
Exhibit 05: NDA filings: Global diabetic therapeutic market
Exhibit 06: Phase III pipeline portfolio: Global diabetic therapeutic market
Exhibit 07: Phase II pipeline portfolio: Global diabetic therapeutic market
Exhibit 08: Phase I pipeline portfolio: Global diabetic therapeutic market
Exhibit 09: Pre-clinical pipeline portfolio: Global diabetic therapeutic market
Exhibit 10: Pipeline portfolio for discovery stage molecules: Global diabetic therapeutic market
Exhibit 11: Market snapshot of global diabetic therapeutic market 2016-2021
Exhibit 12: Overview of global diabetic therapeutic market 2016-2021
Exhibit 13: Global diabetic therapeutic market 2016-2021 ($ billions)
Exhibit 14: Prospects of the global diabetic therapeutic market
Exhibit 15: Vendors’ strategies and the un-addressed needs for global diabetic therapeutic market
Exhibit 16: Global diabetic therapeutic market snapshot: Developed and emerging markets 2016
Exhibit 17: Factors affecting the insulin therapies
Exhibit 18: Global diabetic therapeutic market: Present and outlook and its impact
Exhibit 19: Five forces analysis
Exhibit 20: Information on key marketed diabetic drugs
Exhibit 21: Product profiles of marketed products: Standard insulin therapies
Exhibit 22: Product profiles for marketed products: Non-insulin therapies – DPP-4 class
Exhibit 23: Product profiles for marketed products: Non-insulin therapies – GLP-1 class
Exhibit 24: Product profiles for marketed products: Non-insulin therapies – SGLT2s class
Exhibit 25: Segmentation of global diabetic therapeutic market by type of disease (2016)
Exhibit 26: Market overview of global type 1 diabetes market 2016-2021
Exhibit 27: Opportunity analysis of global type 1 diabetes market
Exhibit 28: Global type 1 diabetes market 2016-2021 ($ billions)
Exhibit 29: Market overview of global type 2 diabetes market 2016-2021
Exhibit 30: Opportunity analysis of global type 2 diabetes market
Exhibit 31: Global type 2 diabetes market 2016-2021 ($ billions)
Exhibit 32: Global gestational diabetes market 2016-2021 ($ billions)
Exhibit 33: Overview of global diabetic therapeutic market by drug class, 2016
Exhibit 34: Snapshot of global diabetic therapeutics market by geography
Exhibit 35: Global diabetes therapeutics market segmentation by region: Market growth lifecycle analysis 2016
Exhibit 36: Diabetic therapeutic market revenue by geography 2016-2021 ($ billions)
Exhibit 37: Overview of diabetic therapeutic market in Americas
Exhibit 38: Diabetic therapeutic market in Americas 2016-2021 ($ billions)
Exhibit 39: Overview of diabetic therapeutic market in US
Exhibit 40: Opportunity analysis: Diabetic therapeutic market in US
Exhibit 41: PESTLE analysis: Diabetic therapeutic market in US
Exhibit 42: Overview of diabetic therapeutic market in EMEA
Exhibit 43: Diabetic therapeutic market in EMEA 2016-2021 ($ billions)
Exhibit 44: Share of diabetic therapeutic market in EMEA 2016
Exhibit 45: Overview of diabetic therapeutic market in Europe
Exhibit 46: Diabetic therapeutic market: Regional outlook of Europe, 2016 and 2021
Exhibit 47: Opportunity analysis: Diabetic therapeutic market in Europe
Exhibit 48: PESTLE analysis: Diabetic therapeutic market in Europe
Exhibit 49: Overview of diabetic therapeutic market in Germany
Exhibit 50: Opportunity analysis: Diabetic therapeutic market in Germany
Exhibit 51: Overview of diabetic therapeutic market in UK
Exhibit 52: Opportunity analysis: Diabetic therapeutic market in UK
Exhibit 53: Overview of diabetic therapeutic market in France
Exhibit 54: Opportunity analysis: Diabetic therapeutic market in France
Exhibit 55: Overview of diabetic therapeutic market in Italy
Exhibit 56: Opportunity analysis: Diabetic therapeutic market in Italy
Exhibit 57: Overview of diabetic therapeutic market in Spain
Exhibit 58: Opportunity analysis: Diabetic therapeutic market in Spain
Exhibit 59: Overview of diabetic therapeutic market in APAC
Exhibit 60: Diabetic therapeutic market: Regional outlook, APAC, 2016 and 2021
Exhibit 61: Diabetic therapeutic market in APAC 2016-2021 ($ billions)
Exhibit 62: Overview of diabetic therapeutic market in China
Exhibit 63: Opportunity analysis: Diabetic therapeutic market in China
Exhibit 64: Pest analysis: Diabetic therapeutic market in China
Exhibit 65: Overview of diabetic therapeutic market in India
Exhibit 66: Opportunity analysis: Diabetic therapeutic market in India
Exhibit 67: PESTLE analysis: Diabetic therapeutic market in India
Exhibit 68: Impact of drivers and challenges in global diabetes therapeutic market
Exhibit 69: Impact of drivers
Exhibit 70: Impact of drivers and challenges
Exhibit 71: Impact of trends in global diabetic therapeutic market
Exhibit 72: Oral insulin pipeline portfolio
Exhibit 73: Key technological integrations
Exhibit 74: Regenerative medicines under development for the treatment of diabetes
Exhibit 75: Competitive structure analysis of global diabetic therapeutic market 2016
Exhibit 76: Top-selling diabetic therapeutics based on sales 2015 ($ billions)
Exhibit 77: Geographical presence of key vendors
Exhibit 78: Competitive scenario: Global diabetic therapeutic market vendors 2016-2021
Exhibit 79: Oramed Pharmaceuticals: Pipeline products
Exhibit 80: Novo Nordisk: Key products in diabetes market
Exhibit 81: Novo Nordisk: Profile
Exhibit 82: Novo Nordisk: Strength analysis
Exhibit 83: Novo Nordisk: Strategy assessment
Exhibit 84: Novo Nordisk: Opportunity assessment
Exhibit 85: Sanofi: Key product offerings in diabetes market
Exhibit 86: Sanofi: Profile
Exhibit 87: Sanofi: Strength analysis
Exhibit 88: Sanofi: Strategy assessment
Exhibit 89: Sanofi: Opportunity assessment
Exhibit 90: Merck: Profile
Exhibit 91: Merck: Strength analysis
Exhibit 92: Merck: Strategy assessment
Exhibit 93: Merck: Opportunity assessment
Exhibit 94: Eli Lilly: Top-selling diabetic drugs in 2015
Exhibit 95: Eli Lilly: Profile
Exhibit 96: Eli Lilly: Strategy assessment
Exhibit 97: Eli Lilly: Opportunity assessment
Exhibit 98: AstraZeneca: Top-selling diabetes drugs in 2015
Exhibit 99: AstraZeneca: Profile9
Exhibit 100: AstraZeneca: Strength analysis
Exhibit 101: AstraZeneca: Strategy assessment
Exhibit 102: AstraZeneca: Opportunity assessment
【レポート販売概要】
■ タイトル：糖尿病治療薬の世界市場2017-2021■ 英文：Global Diabetic Therapeutic Market 2017-2021
■ 発行日：2017年2月1日
■ 調査会社：Technavio
■ 商品コード：IRTNTR11800
■ 調査対象地域：グローバル
- 肺炎球菌性髄膜炎(Pneumococcal Meningitis)：世界の治験レビュー2014年下半期版Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Pneumococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pneumococcal Meningitis. It includes an overview of the trial numbers …
- 世界のマザーボード産業動向This research report presents industry size and value forecast and recent quarter review of the worldwide motherboard industry. The report includes shipment volume and value, shipment breakdowns by maker, ASP, and price trends. The report also examines manufacturer rankings, assembly levels, CPU connector adoption, production locations, shipment destinations, and business types, and provides assem …
- 圧縮空気式電力貯蔵システムの世界市場2015-2019About Compressed Air Energy Storage Compressed air energy storage, as the name suggests, is a technique for storing energy by using compressed air. Energy is generally stored for utilizing it later to meet the high demand during peak hours. Growing interest in energy storage by utilizing renewable energy source has led to an upsurge in new and more advanced energy storage techniques. Compressed ai …
- 世界の貴金属産業分析：Analyzing the Global Precious Metals IndustryThe category of precious metals generally includes silver, gold, platinum, palladium, diamonds and rhodium. The years 2008-2012 have been a period of fluctuating growth for the global precious metals industry. However, growth is seen to be stabilizing recently and the industry is expected to grow at a good growth rate to the year 2017. Aruvian Research analyzes the global precious metals industry …
- バンカーオイルの世界市場2018-2022About Bunker Oil Bunker fuels are also known as marine fuels and are mainly divided into two categories, namely, residual fuel (heavy fuel oil) and the distillates. Marine fuels are supplied to the shipping industry for using them in ships’ bunkers to power their engines. Technavio’s analysts forecast the global bunker oil market to grow at a CAGR of 3.74% during the period 2018-2022. Covered in t …
- 油圧アキュムレータの世界市場2017-2021ABSTRACTAbout Hydraulic Accumulators The pressure built up inside the storage tank is provided by an external source, which is either in the form of compressed gas or a raised weight. The traditional hydraulic accumulators operated with the help of weights. The weight is attached to the top of the piston, and due to the gravitational force on the weight, potential energy is developed in the accumu …
- デマンドレスポンスマネジメントシステム（DRMS）の世界市場分析：技術別（従来型、自動型）、コンポーネント別（ハードウェア、ソフトウェア）、用途別（住居用、産業用、商業用）、地域別、セグメント予測、2014-2025The global demand response management system (DRMS) market size is expected to reach USD 35.9 billion by 2025, according to a new report by Grand View Research, Inc. The integration of Demand Response (DR) with smart grids and the rising awareness and adoption of automated DRMS by utilities and customers are believed to be the key growth drivers. DRMS acts as a crucial arrangement for balancing en …
- ゲノミクスの世界市場予測（～2022年）：装置/システム、消耗品、サービスThe global Genomics market is expected to reach USD 23.88 Billion by 2022 from USD 14.71 Billion in 2017, at a CAGR of 10.2%. The growth of this market is majorly driven by the rise in research activities in the field of genomics; increasing number of start-up companies; growing focus personalized medicine, growing investments, grants, and funds by the government; and increasing application of gen …
- 世界の次世代シーケンシング(NGS)市場：プラットフォーム、バイオインフォマティクス、技術、用途The global next generation sequencing market is dynamic and witnessing many changes with new products being introduced. The global NGS market will be worth $2.5 billion in 2014 and is poised to reach $8.7 billion by 2020. The NGS market segments such as pre-sequencing products and services, NGS platforms, sequencing services and data analysis/bioinformatics are rapidly growing markets. The overall …
- 世界の地熱ポンプ（GHP）システム市場（2014-2018）TechNavio's analysts forecast the Global Geothermal Heat Pump (GHP) System market to grow at a CAGR of 15.50 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to reduce the dependence on fossil-fuels. The Global GHP System market has also been witnessing the increase in technological advancement. However, the need for high levels of initial in …
- 電動アシスト自転車の世界市場2015-2019Pedelec, an acronym for pedal assisted electric cycle, is an electric motor-supported bicycle. The chargeable battery-supported electric motor is intended to aid in pedalling. The various advantages of the pedelec are listed below: Apart from the aforementioned advantages, pedelecs also save energy by using electronic controllers for automatically cutting down the motor's power whenever the rider …
- 製氷機の世界市場2017-2021An ice maker is a kind of refrigeration machinery used to produce ice. The size of an ice maker varies depending upon the requirement. The food service equipment (FSE) segment includes equipment for primary cooking, food preparation, refrigeration and ice machine, serving, storage and handling, and warehousing, and foodservice disposables. In 2016, the global FSE market was $97.12 billion, which i …
- レディーミックスコンクリートの世界市場2019-2023Global Ready-mix Concrete Market: About this market Ready-mix concrete is a construction material manufactured in a factory or a plant within specific guidelines such as 3 parts aggregates, 2 parts water, and 1-part cement. Technavio’s ready-mix concrete market analysis considers sales from both non-residential and residential. Our analysis also considers the sales of ready-mix concrete in APAC, E …
- 世界の電子戦（Electronic Warfare）市場The global electronic warfare (EW) market is currently going through a period of growth, as many countries are realising its benefits and attempting to expand their capabilities therein. There has also been a significant R&D effort in all three submarkets, with attack in particular expected to undergo significant growth. European and Northern American markets will keep contracting throughout the p …
- 酸性スフィンゴミエリナーゼ欠乏症(Acid Sphingomyelinase Deficiency/ニーマンピック病)：治療薬開発パイプライン動向（2015年上半期版）Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) - Pipeline Review, H1 2015’, provides an overview of the Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acid Sph …
